Tibor Keler - Jun 13, 2024 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
EXECUTIVE VP & CSO
Signature
/s/ Sam Martin, attorney-in-fact for Tibor Keler
Stock symbol
CLDX
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/17/2024, 04:13 PM
Previous filing
Jun 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (right to buy) Award $0 +93K $0.00 93K Jun 13, 2024 Common Stock 93K $36.43 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
F2 25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.